Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Peter Ashley Marks

Director at Alterity Therapeutics Ltd (ATHE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$125K
Total bought / sold$24K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 8SEC ATHEAlterity Therapeutics Ltd Buy 47,620191,340 held (+33%) $0.50 $24K +524.0%
  • Buy

    Director Peter Ashley Marks bought $24K of ATHE at $0.50 — first open-market purchase in our records; raises the stake by 33%.